Multiple myeloma: open trials in Finland

11 open trials have a site in Finland. Registry data; only the trial team decides who can take part.

NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Celgene
Helsinki · Kuopio
Registry updated 2026-10-30
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
HUS-Yhtymae, Helsinki · Oulu University Hospital, Oulu · Turku University Hospital, Turku
Registry updated 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
HUS-Yhtymae, Helsinki · Kymenlaakson keskussairaala, Kotka · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Turku University Hospital, Turku
Registry updated 2026-10-27
NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Trial Treatment · Phase 2 · Sanofi
Helsinki
Registry updated 2026-10-15
2023-510173-34-00
A long-term follow-up study for patients treated with Galapagos CAR T cell therapies
Trial Treatment · Phase 3 · Lakefront Biotherapeutics
HUS-Yhtymae, Helsinki
Registry updated 2026-09-11
NCT05020236
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Trial Treatment · Phase 3 · Pfizer
Helsinki University Central Hospital Meilahden Kolmiosairaala, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-08-24
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Trial Treatment · Phase 3 · Pfizer
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-08-24
NCT05714839
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Trial Treatment · Phase 1/2 · GlaxoSmithKline
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-08-19
NCT07757412
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
Trial Treatment · Phase 2 · Odense University Hospital
Helsinki University Central Hospital Meilahden Kolmiosairaala, Helsinki
Registry updated 2026-08-11
2023-505775-70-00
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
Trial Treatment · Phase 2 · European Myeloma Network B.V.
Helsinki University Central Hospital, Helsinki
Registry updated 2026-08-03
NCT06932562
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Trial Treatment · Phase 3 · European Myeloma Network B.V.
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio
Registry updated 2026-03-25

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error